Klinisk evidens for behandling av brannskader
Bla gjennom vår evidens på håndtering av delhudsbrannskader eller fiksering av hudtransplantater.
Ulana Pawlak and Phil Davies
Mepilex® Ag in the management of partial-thickness burns: A review of the clinical evidence
Gee Kee E.L et al.
Randomised controlled trial of three burns dressings for partial thickness burns in children
Aggarwala S. et al.
Treatment of partial thickness burns: A prospective, randomized controlled trial comparing four routinely used burns dressings in an ambulatory care setting
Gee Kee E. ET AL.
Cost-effectiveness of silver dressings for paediatric partial thickness burns: An economic evaluation from a randomized controlled trial
Silverstein P. et al.
An open, parallel, randomized, comparative, multicenter studyto evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream
Phil Davies, Sara McCarty and Kristina Hamberg
Silver-containing foam dressings with Safetac: a review of the scientific and clinical data
Tang H. et al.
An open, parallel, randomised, comparative, multicenter investigation evaluating the efficacy and tolerability of Mepilex® Ag vs silver sulfadiazine in the treatment of deep partial-thickness burn injuries
For dype brannskader er en kombinasjon av eksisjon og transplantasjon generelt å foretrekke (Orgill, 2009). Pasienter med dype brannskader har ofte smerte og engstelse, og derfor er valg av riktig bandasje viktig for både hudtransplantat og donorsted.
Poster-tittel: Clinical investigation of the performance and safety of a soft silicone wound contact layer containing silver in the treatment of skin grafts and a soft silicone transfer dressing containing silver in the treatment of donor sites in surgical burn patients. Poster, SAWC Spring 2017
Forfatter: Paul Glat et al.
Donorsteder kan være utfordrende å behandle da disse nye sårene kan forårsake mer smerte og/eller arrdannelse hos pasienten. Å velge riktig bandasje er essensielt i behandlingen av donorsteder.
Poster-tittel: A post market follow up study to demonstrate the safety and efficacy of a gelling fibre product (Exufiber®) for the management of donor sites.
Fortfatter: Matilda Karlsson R.N and PhD
Poster-tittel: An open, non-comparative, post-market clinical follow-up investigation to confirm performance and safety of Exufiber® when used as intended on donor sites
